| DFSVX | LRSRX | DFSVX / LRSRX | |
| Total Expense Ratio | 0.31 | 1.46 | 21% |
| Annual Report Gross Expense Ratio | 0.31 | 1.46 | 21% |
| Fund Existence | 33 years | 18 years | - |
| Gain YTD | 9.431 | 6.599 | 143% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 17.9B | 384M | 4,661% |
| Annual Yield % from dividends | 1.58 | 0.14 | 1,117% |
| Returns for 1 year | 17.52 | -0.14 | -12,324% |
| Returns for 3 years | 35.91 | 7.26 | 495% |
| Returns for 5 years | 55.54 | -7.96 | -698% |
| Returns for 10 years | 121.92 | -24.37 | -500% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MCYCX | 14.37 | 0.48 | +3.46% |
| NYLI Candriam Emerging Markets Eq Cl C | |||
| EQIRX | 16.35 | 0.22 | +1.36% |
| Allspring Emerging Markets Eq Advtg R6 | |||
| FVDKX | 40.52 | N/A | N/A |
| Fidelity Value Discovery K | |||
| GSURX | 62.38 | -0.70 | -1.11% |
| Goldman Sachs US Equity Insights R | |||
| VPMAX | 194.37 | -2.54 | -1.29% |
| Vanguard PRIMECAP Adm | |||